Ifnopime TZ 250mg/31.25mg Injection
Marketer
Albia Biocare
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Ifnopime TZ 250mg/31.25mg Injection
Combiflox TZ Injection (250mg/31.25mg) combines two antibiotics to combat diverse bacterial infections by hindering microbial proliferation. Administration must be solely under a doctor's guidance; adhere strictly to the prescribed schedule, completing the entire course regardless of symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) are possible but usually subside. Severe or persistent side effects necessitate immediate medical attention. Seek immediate help for allergic responses (rash, itching, swelling, breathing difficulties). Inform your physician of all current medications, especially if pregnant or breastfeeding, before starting this treatment. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing drowsiness or dizziness.
Uses of Ifnopime TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ifnopime TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ifnopime TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Ifnopime TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ifnopime TZ 250mg/31.25mg Injection works:
Ifnopime TZ 250mg/31.25mg Injection combines cefepime, a broad-spectrum antibiotic, with tazobactam, a beta-lactamase inhibitor. Cefepime's antibacterial action stems from its disruption of bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial enzymes that would otherwise neutralize cefepime, thereby improving cefepime's efficacy and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Ifnopime TZ 250mg/31.25mg Injection necessitates careful consideration. Seek medical advice before combining.
PregnancySAFE IF PRESCRIBED
The injectable medication Ifnopime TZ 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Ifnopime TZ 250mg/31.25mg Injection during lactation is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Following administration of Ifnopime TZ 250mg/31.25mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Patients with kidney impairment should use Ifnopime TZ 250mg/31.25mg Injection cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
In patients with liver impairment, Ifnopime TZ 250mg/31.25mg Injection appears to be well-tolerated. Available evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Ifnopime TZ 250mg/31.25mg Injection :
Should you inadvertently skip a dose of Ifnopime TZ 250mg/31.25mg Injection, seek immediate medical advice.
Facts to Know About Ifnopime TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Antimicrobial Agents |
3,018 People bought this recently